Evidence map›Paper›PMID 38235005›Full record

ArticleHealth promotion perspectives2023

The rise of India's global health diplomacy amid COVID-19 pandemic.

Vijay Kumar Chattu, Bawa Singh, Fnu Kajal, Chakrapani Chatla, Soosanna Kumary Chattu, Sanjay Pattanshetty, K Srikanth Reddy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health promotion perspectives, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vijay Kumar ChattuDepartment of Occupational Science & Occupational Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada.ORCID https://orcid.org/0000-0001-9840-8335
Bawa SinghDepartment of South and Central Asian Studies, School of International Studies, Central University of Punjab, Bathinda 151401, India.ORCID https://orcid.org/0000-0003-4832-0938
Fnu KajalDepartment of Health Promotion Sciences, University of Arizona, Tucson, AZ 85719, USA.ORCID https://orcid.org/0000-0002-7971-0237
Chakrapani ChatlaGlobal Health Equity, Public Health Department, Thermo Fisher Scientific, Hyderabad, Telangana.ORCID https://orcid.org/0000-0002-3259-0602
Soosanna Kumary ChattuCenter for Evidence-based Diplomacy (CEBD), Global Health Research and Innovations Canada (GHRIC), Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-2365-7836
Sanjay PattanshettyDepartment of Global Health Governance, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.ORCID https://orcid.org/0000-0003-2854-2613
K Srikanth ReddyCenter for Evidence-based Diplomacy (CEBD), Global Health Research and Innovations Canada (GHRIC), Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-8035-9034

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has highlighted the importance of global health diplomacy (GHD), with India emerging as a key player. India's commitment to GHD is demonstrated by its active participation in regional and multilateral projects, pharmaceutical expertise, and large-scale manufacturing capabilities, which include the production and distribution of COVID-19 vaccines and essential medicines. India has supported nations in need through bilateral and multilateral platforms, providing vaccines to countries experiencing shortages and offering technical assistance and capacity-building programs to improve healthcare infrastructure and response capabilities. India's unique approach to GHD, rooted in humanitarian diplomacy, emphasized collaboration and empathy and stressed the well-being of humanity by embracing the philosophy of "Vasudhaiva Kutumbakam," which translates to "

Indexed as

COVID-19Essential medicinesGlobal healthHealth diplomacyIndiaPandemicPharmaceuticalsPolicyVaccines

Identifiers

PMID38235005
PMCPMC10790121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.